Clinical trials play a critical role in the development of new treatments and are the culmination of years, often decades, of work done by researchers to find ways to slow, treat, or even cure diseases like Alzheimer's disease, macular degeneration, and glaucoma. Unlike earlier phases of research, clinical trials are completely dependent on the volunteer participation of patients and others who are personally invested in seeing new treatments become available.
BrightFocus Foundation is here to help you understand what clinical trials are, what volunteering for a trial means to you, what you should consider before participating, and how you are helping researchers impact the lives of millions of people. This brochure will also address other ways you can help health research if the clinical trial course is not for you.
What Is Involved in Bringing a New Treatment to Market?
A new treatment or cure cannot come fast enough for someone who suffers from a mind- or sight-stealing disease. However, it is a long and difficult journey to bring new treatments to market, one that involves decades of painstaking research and testing, and billions of dollars in cost.
The word "treatment" most often refers to a new drug that can cure, modify, or reduce the symptoms of a disease. However, it may also refer to a new technology or device, or a new approach to surgery. This brochure focuses on clinical trials leading to treatments and devices that are regulated and approved by the U.S. Food and Drug Administration (FDA). There may be other dietary and lifestyle approaches to preventing or treating a disease that do not fall under FDA jurisdiction, such as supplements, but they are not discussed here.
The journey from a scientific breakthrough by a researcher to a treatment you can access at your local pharmacy is a long one. Even after positive results are reported on a promising idea, there are many twists and turns on its path to FDA approval.
The final stages on this path are clinical trials that depend on the volunteer participation of patients and others who hope to find better approaches to managing diseases. In return for enrolling, many trial-related expenses are often paid. You may have the opportunity to participate in a clinical trial that helps advance new treatments and cures.
What Are Clinical Trials?
Clinical trials are the final phase of the research process, and the step in the process that ultimately determines whether or not a treatment will be approved for use by humans. Extensive research has already taken place in laboratories and in animal models before human trial volunteers ever get involved. During this process, the list of potential treatments is whittled down to a small number of promising candidates selected to go through the rigor of testing in humans.
Why Are Clinical Trials Necessary?
Clinical trials are undertaken to test whether a new drug or device is safe and effective, which requires successive levels of proof that it will effectively treat people who have a certain disease or condition. This series of clinical hurdles is referred to as Phase 1, 2, and 3 clinical trials, and each phase is closely regulated by the FDA to ensure that all steps are done properly and adhere to strict standards governing the drug approval process.
By establishing safety and effectiveness, these trials will ultimately determine whether a drug or device will receive approval by the FDA, and the conditions for which they can be marketed and sold in the United States.
Clinical trials answer the following questions:
- Is a new device or treatment safe to use?
- Does the new treatment have a positive or negative effect on patients' disease?
- Is the new treatment better than the current standard treatment, or other treatments that might be available?
- Which patients benefit the most from the new treatment?
Today's clinical trials will lead to new standards of care in the future.
How Do Clinical Trials Work?
Each of the three phases of clinical testing has a specific purpose in determining the safety of a treatment for use by the public.
Phase 1 clinical trials evaluate the safety of a drug or treatment and to determine how well it works. This testing normally takes place with a small group of healthy volunteers. The trial sponsor monitors potentially serious adverse events—that is, any toxic, undesirable, or unwanted effect that causes death or danger to health, like a disability or permanent damage, birth defect, heart attack, or other serious medical condition.
At the end of Phase 1, the results are collected, analyzed, and submitted to the FDA for permission to proceed to Phase 2 clinical trials. However, if the results show that the treatment was associated with one or more serious adverse events, then the FDA may not give permission to proceed to Phase 2. Sometimes early clinical trials are discontinued for that reason, or the sponsor may voluntarily withdraw the treatment from regulatory consideration.
If the trial meets the primary outcomes, as proposed in the application to the FDA, then the FDA permits the trial to proceed to Phase 2.
Phase 2 clinical trials test the right dosage and effectiveness in treating a particular disease. This testing normally takes place with a larger number of volunteers who have the disease, and typically involves assigning participants to different treatment groups, where each group can receive different doses or delivery of the treatment.
At the end of Phase 2 trials, the health of the group(s) of patients who received the different types of treatment is compared to the control groups. However, if the results show that the treatment did not work better than the current standard of care or even caused acceleration of the disease or other unexpected serious adverse events, the FDA may not give permission to proceed to Phase 3, and the trial may be discontinued from the regulatory approval process until modifications can be made.
Phase 3 clinical trials are the ultimate test of whether a treatment is safe and effective for a wide variety of people, and typically involve a much larger group of volunteers than Phase 1 and 2 trials. Just like Phase 2 trials, the plan normally involves assigning participants to treatment or control groups. There can be more than one treatment group, especially if the treatment involves a combination of drugs or different components. Participants can expect to receive either the treatment being tested or an equivalent single or combined treatment for comparison (treatment groups), or a placebo treatment (control group).
After completion, the health of the patients who received the different types of treatment are compared to the control groups.
If successful, sponsors may now apply for a New Drug Application (NDA). The NDA contains all of the discoveries made at every stage of the process (starting from the basic investigation/drug discovery stage through the results of the Phase 3 clinical trials), and is submitted to the FDA for their consideration.
If approved, the trial sponsors will now have the necessary approval to manufacture and sell these new treatments, making them available to patients.
Clinical Trials at a Glance
This table compares Phase 1-4 trials by purpose, number of participants, and approximate length of time.
Type of Clinical Trial
Treatments continuing to next stage (%)
SAFETY & DOSAGE
20-100 healthy volunteers or people with the disease or condition
Approx. 70% (may vary by disease and severity)
EFFICACY & SIDE EFFECTS
Hundreds of people with the disease or condition
Several months to 2 years
SAFETY & EFFICACY
Hundreds to thousands of people with the disease or condition
POSTMARKET SAFETY MONITORING
All people using the treatment after it has been approved
Ongoing after FDA approval
Does the FDA Monitor a New Treatment after Approval?
They do. Phase 4 clinical trials (also called Post-Market Surveillance and Adverse Event Reporting) take place after a treatment is approved by the FDA to be manufactured and sold in the United States. For the entire time a treatment is on the market (or longer), the FDA monitors its impact on public safety and whether it has been associated with any potential serious adverse events.
Who Can Participate in Clinical Trials?
People with a medical condition as well as healthy individuals may consider participating in clinical trials. Each trial has its set of guidelines, or protocols, and volunteers must meet the criteria as outlined to qualify for enrollment. Before making a decision and giving informed consent, each person should learn as much information as possible about the trial.
Many people choose to become involved because they hope to improve their health or be cured, and also wish that for others with the same condition. Whether that happens depends on the many factors, and yet there are many additional benefits to participation:
- You are helping the cause of research.
- You may find a treatment better than your current one.
- Your participation may result in new treatments for people who are now suffering, or will later.
- You have the satisfaction of knowing you are helping speed the availability of new treatments in health care.
- You help medical science know more about individual diseases.
Enrolling in clinical trials requires a time commitment, even to learn whether you are eligible. And there are possible risks to consider along with the benefits. There may be side effects, or the treatment you receive may be no more effective than the current care you are receiving. However, even if that happens, you will have helped in some important ways listed above. The decision is yours to make with your family and doctor.
How Can I Learn about Clinical Trials?
Your primary care provider or a specialist may tell you about a clinical trial if he/she thinks you might qualify as a candidate. However, some physicians may have little or no contact themselves with clinical research.
Stay informed. You may initially find trials that you are not qualified or eligible to enroll in. Check back periodically to see if new trials have been listed, and share the information with others who may be eligible or interested. This brochure provides a list of resources to help you become informed about clinical trials. You can also find this information at www.brightfocus.org/clinical-trial-resources.html
What Should I Consider When Making a Decision about Participation?
Many factors have to be weighed when reaching a decision about whether to enroll in a clinical trial. There should be a full discussion between you and your medical care team. Do not hesitate to ask additional questions of the research team and healthcare professionals associated with the clinical trial. You may want to bring a family member or caregiver with you, or even a recording device like your cell phone to help make sure all of your questions are answered and documented for future reference.
Can I Leave a Clinical Trial?
Participation in a clinical trial is voluntary, which means you can leave a clinical trial at any time. Before you leave a clinical trial, please let the research team know you have decided to withdraw and your reasons for leaving the study. Also ask them for direction on how your participation may impact your care outside the trial. This will help the team to prepare information for their detailed report on the clinical trial to the FDA.
Are There Other Ways to Participate in Health Research?
Maybe you have decided a drug approval trial is not for you. Or you cannot find one convenient to your location. Or you do not qualify based on the entry criteria. If any of these are true, there are still ways you can participate in health research. You may still have the opportunity to participate in research.
Participate in Other Studies
Some prevention research looks at whether things like vitamins, exercise, or similar lifestyle changes that don't require FDA approval might prevent a disease or condition from developing or getting worse. There are long-term studies (sometimes called "longitudinal studies") that track healthy people or people with a particular disease for years to see how they fare over time. You will find studies like these listed at www.clinicaltrials.gov and other resources listed at the end of this brochure, and they may be suitable for people who are not comfortable being randomized into a treatment or non-treatment arm.
Join Registries and Genetic Research Efforts
If you are being treated for a disease or condition, your doctor may be able to contribute information about your health and treatment to a "registry" or data bank of information kept on large numbers of people with the disease. In some cases, these registries involve sampling and keeping track of genetic information; thanks to millions of people worldwide who were willing to provide this information (usually anonymously), new genes associated with diseases and conditions are being discovered. And if you happen to have a highly inheritable disease or form of a disease, there are researchers who might like to study you and your family to gain more information.
There’s an enormous amount of information to be gained from postmortem studies of tissue donated by individuals who had a disease or condition. Most donor registries are nonprofit organizations that provide these specimens to medical schools and research labs at minimal or no cost. Healthy individuals also have the option of donating their eyes and other organs for use by the living. More information is listed in the resources, below.
Follow and Share Results
While it takes a long time for a new treatment to be discovered and approved, scientific research yields new information and small breakthroughs every single day. At BrightFocus, this information appears in our print newsletters and on our website. Keep hope alive by tuning into these accomplishments and informing others about scientific progress.
Where Can I Find More Information?
Services to Identify Clinical Trials and Sign up as a Volunteer:
Antidote. Antidote helps you discover new treatment options being developed by medical researchers. They put technology to work so that by answering a few health questions, their smart search engine quickly and easily finds a trial that’s right for you.
CenterWatch Clinical Trials Listing Service. This service provides information about clinical research, including listings of active industry and government-sponsored clinical trials, research on new drug therapies, and drugs recently approved by the FDA.
Clinicaltrials.gov. An online registry and results database hosted by National Institutes of Health (NIH) that lists all publicly and privately supported clinical studies being conducted with human participants around the world. Follow prompts to look for active clinical trials located near you for a specific medical condition.
eyeGENE®. Aims to advance studies of eye diseases and their genetic causes by giving researchers access to DNA samples, clinical information, and patients looking to participate in research studies and clinical trials.
National Institutes of Health (NIH). Provides information on government-sponsored human trials and recruitment, with locations, purpose, eligibility requirements, and phone contacts.
They also provide information on health registries:
ResearchMatch. This free and secure registry brings together people who are trying to find research studies, and researchers who are looking for people to participate in their studies.
Additional Resources to Answer Your Questions:
Center for Information and Study on Clinical Research Participation (CISCRP). A nonprofit organization that educates the public about clinical research; what it means to be a clinical research volunteer; and questions you should consider before, during, and after your participation in clinical trials.
U.S. Food and Drug Administration (FDA). The “For Patients” section of the FDA website links to information about clinical trials and the drug and device approval process.
Drug Safety & Reporting:
MedWatch (FDA Safety Information and Adverse Event Reporting Program). A website maintained by the FDA with safety information about drugs commercially available in the United States, including a searchable database. Consumers and healthcare professionals can voluntarily report a serious adverse event, product quality problem, or another type of failure that is suspected to be associated with the use of an FDA-regulated drug, biologic, medical device, dietary supplement, or cosmetic. Suspected counterfeit medical products can also be reported through the same online reporting form.
Information About Online Reporting
Organ and Tissue Donation:
Eye Bank Association of America. A network of eye banks around the country recover corneal tissue from donors and prepare it to surgeons’ specifications for sight-restoring transplant procedures.
NIH NeuroBioBank (NBB). Supported by the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the NBB brings together multiple stakeholders to facilitate research advancement through the collection and distribution of human post-mortem brain tissue.
U.S. Department of Health and Human Services. An online resource offering information about “the basics” of organ, eye, and tissue donation, and about who these gifts may help under the U.S.-run Organ Procurement and Transplantation Network.
The above organizations are not affiliated with BrightFocus Foundation. BrightFocus is not responsible for the content of these websites and does not endorse any particular programs offered by these organizations.
The information provided in this section is a public service of BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.